DE69737198D1 - Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung - Google Patents

Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung

Info

Publication number
DE69737198D1
DE69737198D1 DE69737198T DE69737198T DE69737198D1 DE 69737198 D1 DE69737198 D1 DE 69737198D1 DE 69737198 T DE69737198 T DE 69737198T DE 69737198 T DE69737198 T DE 69737198T DE 69737198 D1 DE69737198 D1 DE 69737198D1
Authority
DE
Germany
Prior art keywords
production
herpesvirus
composition
mutual protective
mutual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69737198T
Other languages
English (en)
Other versions
DE69737198T2 (de
Inventor
Joseph Macek
K Brown
O Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of DE69737198D1 publication Critical patent/DE69737198D1/de
Application granted granted Critical
Publication of DE69737198T2 publication Critical patent/DE69737198T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/27—Equine rhinopneumonitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69737198T 1996-08-16 1997-08-05 Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung Expired - Fee Related DE69737198T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US698630 1996-08-16
US08/698,630 US5853715A (en) 1996-08-16 1996-08-16 Cross-protective equine herpesvirus preparations and method of making and using the same
PCT/US1997/014840 WO1998006427A2 (en) 1996-08-16 1997-08-05 Cross-protective equine herpesvirus preparations and method of making and using the same

Publications (2)

Publication Number Publication Date
DE69737198D1 true DE69737198D1 (de) 2007-02-15
DE69737198T2 DE69737198T2 (de) 2007-11-08

Family

ID=24806044

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737198T Expired - Fee Related DE69737198T2 (de) 1996-08-16 1997-08-05 Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung

Country Status (13)

Country Link
US (1) US5853715A (de)
EP (1) EP0929315B1 (de)
JP (1) JP2000516622A (de)
CN (1) CN1228029A (de)
AT (1) ATE350058T1 (de)
AU (1) AU714418B2 (de)
BR (1) BR9711138A (de)
CA (1) CA2263201C (de)
DE (1) DE69737198T2 (de)
DK (1) DK0929315T3 (de)
ES (1) ES2281094T3 (de)
NZ (1) NZ334154A (de)
WO (1) WO1998006427A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216054A1 (de) * 1999-09-10 2002-06-26 Akzo Nobel N.V. Temperaturempfindlicher pferdeherpesvirus und lebendimpfstoff davon
EP1129722A1 (de) * 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
AR040601A1 (es) * 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110433A (en) * 1976-04-23 1978-08-29 Philips Roxane, Inc. Equine rhinopneumonitis virus
US4083958A (en) * 1976-09-13 1978-04-11 The University Of Kentucky Research Foundation Inactivated equine rhinopneumonitis virus vaccine and use thereof
US4225582A (en) * 1979-03-08 1980-09-30 The University Of Illinois Foundation Vaccine for equine rhinopneumonitis
US5084271B1 (en) * 1984-09-11 1997-08-05 Univ Melbourne Vaccine for equine herpesvirus
ATE117899T1 (de) * 1987-09-28 1995-02-15 Beecham Inc Tgev-virus vom schwein als impfstoff für hunde.
DE4033446A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Impfstoffe gegen equine herpesviren und ihre herstellung
EP0532833A1 (de) * 1991-05-28 1993-03-24 Miles Inc. Pferde-Rhinopneumonitis Impfstoff
US5741696A (en) * 1992-08-07 1998-04-21 Syntro Corporation Recombinant equine herpesviruses
EP0668355B1 (de) * 1993-12-20 1999-04-07 Akzo Nobel N.V. Impstoff zum Schutze von Pferden gegen Pferdeherpesvirus-Infektionen

Also Published As

Publication number Publication date
CA2263201C (en) 2008-04-15
ES2281094T3 (es) 2007-09-16
WO1998006427A3 (en) 1998-05-14
CN1228029A (zh) 1999-09-08
BR9711138A (pt) 1999-08-17
AU4891297A (en) 1998-03-06
DK0929315T3 (da) 2007-04-10
AU714418B2 (en) 2000-01-06
JP2000516622A (ja) 2000-12-12
WO1998006427A2 (en) 1998-02-19
DE69737198T2 (de) 2007-11-08
NZ334154A (en) 2000-07-28
CA2263201A1 (en) 1998-02-19
ATE350058T1 (de) 2007-01-15
US5853715A (en) 1998-12-29
EP0929315A2 (de) 1999-07-21
EP0929315B1 (de) 2007-01-03

Similar Documents

Publication Publication Date Title
DE69726539D1 (de) Schaumglasgegenstand zur vorbereitung von oberflächen, verwendung dafür und verfahren zu dessen herstellung
DE69411181D1 (de) Gegen ultraviolettstrahlung schützende feine kompositteilchen, verfahren zur herstellung derselben und kosmetika
DE69732758D1 (de) Verfahren zur Herstellung eines Aerogels
EP1203817A3 (de) Verbindungen und Verfahren zur Immuntherapie und Diagnose von Tuberkulose
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
DE69411798D1 (de) Isolierten Aderpaaren, sowie Verfahren und Apparat zur Herstellung derselben
DE69726788D1 (de) Aluminiumhydroxid, Verfahren zur Herstellung und Verwendung davon
DE69431358D1 (de) Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
DE69739372D1 (de) Verfahren und zusammensetzungen zur genetisch schützenden und therapeutischen immunisierung
DE59206237D1 (de) Strahlmittel, Verfahren zur Herstellung desselben sowie Verwendung des Strahlmittels
UA35639C2 (uk) Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
DE69008723D1 (de) Gaskissen aufprallschutzvorrichtung und dazugehöriger schichtstoff sowie prozess zur herstellung dieses schichtstoffs.
DE69530350D1 (de) Verfahren zur Herstellung von Fluor enthaltende Silikon-Zusammensetzung
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
DE69737198D1 (de) Sich gegenseitig schützende herpesviruszusammensetzung und verfahren zur deren herstellung und verwendung
DE69610748D1 (de) Polyoxyalkylenblockcopolymere, Verfahren zur Herstellung und ihre Verwendung als Schmiermittel
HUP0102861A2 (hu) Attenuált lóherpeszvírus
DE69701915D1 (de) Verfahren zur Herstellung eines einbügelbaren Einlagestoffs
AU2981395A (en) Method of identifying and producing antigen peptides and use thereof as vaccines
DE59702988D1 (de) Verfahren zur herstellung temporärer schutzüberzüge
DE60031108D1 (de) Verfahren zur Herstellung von Vinylamin-Vinylalkohol-Copolymeren und Verwendung davon
DE69401486D1 (de) Verfahren zur Herstellung 2-cyanoimidazol Derivate
DE69922804D1 (de) Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien
DE69112269D1 (de) Ungesättigte Gruppen und Fluor enthaltende Blockcopolymere, Verfahren zur Herstellung davon und Verwendung.
DE59701804D1 (de) Verfahren zur Herstellung von 2-Methyl-2,4-diaminopentan

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee